Success Metrics

Completion Rate
0%(0/1)
Active Trials
3(75%)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Terminated(1)

Detailed Status

Active, not recruiting3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
3
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

terminated125%
active_not_recruiting375%

Recent Activity

3 active trials
Showing 4 of 4
active_not_recruitingnot_applicable

The ETCHES I Study (Endovascular Treatment of Communicating Hydrocephalus With an Endovascular Shunt)

NCT04758611
active_not_recruitingnot_applicable

Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

NCT05250505
active_not_recruitingnot_applicable

US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

NCT05232838
terminatednot_applicable

Pilot Study to Evaluate the CereVasc® EShunt® System in the Treatment of Communicating Hydrocephalus

NCT05501002

Clinical Trials (4)

Showing 4 of 4 trials
NCT04758611Not Applicable

The ETCHES I Study (Endovascular Treatment of Communicating Hydrocephalus With an Endovascular Shunt)

Active Not Recruiting
NCT05250505Not Applicable

Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

Active Not Recruiting
NCT05232838Not Applicable

US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

Active Not Recruiting
NCT05501002Not Applicable

Pilot Study to Evaluate the CereVasc® EShunt® System in the Treatment of Communicating Hydrocephalus

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4